vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and Tecnoglass Inc. (TGLS). Click either name above to swap in a different company.
Tecnoglass Inc. is the larger business by last-quarter revenue ($245.3M vs $148.6M, roughly 1.7× Azenta, Inc.). Tecnoglass Inc. runs the higher net margin — 10.6% vs -10.4%, a 21.0% gap on every dollar of revenue. On growth, Tecnoglass Inc. posted the faster year-over-year revenue change (2.4% vs 0.8%). Azenta, Inc. produced more free cash flow last quarter ($14.7M vs $11.4M). Over the past eight quarters, Tecnoglass Inc.'s revenue compounded faster (12.8% CAGR vs 4.4%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
Tecnoglass Inc. is a leading manufacturer of high-performance architectural glass, aluminum windows, doors, and associated building components. It primarily caters to residential and commercial construction sectors across North America and Latin America, offering custom, energy-efficient solutions for new construction and renovation projects.
AZTA vs TGLS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $245.3M |
| Net Profit | $-15.4M | $26.1M |
| Gross Margin | 42.9% | 40.0% |
| Operating Margin | -4.9% | 18.3% |
| Net Margin | -10.4% | 10.6% |
| Revenue YoY | 0.8% | 2.4% |
| Net Profit YoY | -15.7% | -44.5% |
| EPS (diluted) | $-0.34 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | $245.3M | ||
| Q3 25 | $159.2M | $260.5M | ||
| Q2 25 | $143.9M | $255.5M | ||
| Q1 25 | $143.3M | $222.3M | ||
| Q4 24 | $147.4M | $239.6M | ||
| Q3 24 | $150.6M | $238.3M | ||
| Q2 24 | $144.3M | $219.7M | ||
| Q1 24 | $136.4M | $192.6M |
| Q4 25 | $-15.4M | $26.1M | ||
| Q3 25 | $50.9M | $47.2M | ||
| Q2 25 | $-48.0M | $44.1M | ||
| Q1 25 | $-47.7M | $42.2M | ||
| Q4 24 | $-11.0M | $47.0M | ||
| Q3 24 | $-6.6M | $49.5M | ||
| Q2 24 | $-6.6M | $35.0M | ||
| Q1 24 | $-137.4M | $29.7M |
| Q4 25 | 42.9% | 40.0% | ||
| Q3 25 | 45.4% | 42.7% | ||
| Q2 25 | 46.2% | 44.7% | ||
| Q1 25 | 43.8% | 43.9% | ||
| Q4 24 | 46.7% | 44.5% | ||
| Q3 24 | 45.5% | 45.8% | ||
| Q2 24 | 44.8% | 40.8% | ||
| Q1 24 | 43.8% | 38.8% |
| Q4 25 | -4.9% | 18.3% | ||
| Q3 25 | 1.2% | 25.1% | ||
| Q2 25 | -1.3% | 24.0% | ||
| Q1 25 | -12.7% | 26.7% | ||
| Q4 24 | -5.9% | 28.0% | ||
| Q3 24 | -3.1% | 28.4% | ||
| Q2 24 | -4.9% | 23.3% | ||
| Q1 24 | -18.1% | 21.3% |
| Q4 25 | -10.4% | 10.6% | ||
| Q3 25 | 32.0% | 18.1% | ||
| Q2 25 | -33.4% | 17.3% | ||
| Q1 25 | -33.3% | 19.0% | ||
| Q4 24 | -7.5% | 19.6% | ||
| Q3 24 | -4.4% | 20.8% | ||
| Q2 24 | -4.5% | 15.9% | ||
| Q1 24 | -100.8% | 15.4% |
| Q4 25 | $-0.34 | $0.57 | ||
| Q3 25 | $1.12 | $1.01 | ||
| Q2 25 | $-1.05 | $0.94 | ||
| Q1 25 | $-1.04 | $0.90 | ||
| Q4 24 | $-0.25 | $1.00 | ||
| Q3 24 | $-0.25 | $1.05 | ||
| Q2 24 | $-0.12 | $0.75 | ||
| Q1 24 | $-2.48 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $104.1M |
| Total DebtLower is stronger | — | $174.4M |
| Stockholders' EquityBook value | $1.7B | $713.1M |
| Total Assets | $2.1B | $1.3B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | $104.1M | ||
| Q3 25 | $279.8M | $127.1M | ||
| Q2 25 | $270.0M | $140.9M | ||
| Q1 25 | $253.6M | $160.2M | ||
| Q4 24 | $377.5M | $137.5M | ||
| Q3 24 | $280.0M | $124.8M | ||
| Q2 24 | $336.5M | $129.5M | ||
| Q1 24 | $353.5M | $138.8M |
| Q4 25 | — | $174.4M | ||
| Q3 25 | — | $114.7M | ||
| Q2 25 | — | $110.6M | ||
| Q1 25 | — | $110.6M | ||
| Q4 24 | — | $111.1M | ||
| Q3 24 | — | $126.8M | ||
| Q2 24 | — | $144.7M | ||
| Q1 24 | — | $160.9M |
| Q4 25 | $1.7B | $713.1M | ||
| Q3 25 | $1.7B | $764.0M | ||
| Q2 25 | $1.7B | $736.0M | ||
| Q1 25 | $1.7B | $685.1M | ||
| Q4 24 | $1.7B | $631.2M | ||
| Q3 24 | $1.8B | $613.3M | ||
| Q2 24 | $2.0B | $574.8M | ||
| Q1 24 | $2.2B | $573.6M |
| Q4 25 | $2.1B | $1.3B | ||
| Q3 25 | $2.1B | $1.2B | ||
| Q2 25 | $2.0B | $1.2B | ||
| Q1 25 | $2.0B | $1.1B | ||
| Q4 24 | $2.0B | $1.0B | ||
| Q3 24 | $2.1B | $996.3M | ||
| Q2 24 | $2.3B | $942.5M | ||
| Q1 24 | $2.6B | $981.6M |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.25× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $31.0M |
| Free Cash FlowOCF − Capex | $14.7M | $11.4M |
| FCF MarginFCF / Revenue | 9.9% | 4.7% |
| Capex IntensityCapex / Revenue | 4.2% | 8.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | $31.0M | ||
| Q3 25 | $2.2M | $40.0M | ||
| Q2 25 | $25.8M | $17.9M | ||
| Q1 25 | $14.4M | $46.9M | ||
| Q4 24 | $29.8M | $61.1M | ||
| Q3 24 | $17.7M | $41.5M | ||
| Q2 24 | $9.8M | $34.5M | ||
| Q1 24 | $8.7M | $33.4M |
| Q4 25 | $14.7M | $11.4M | ||
| Q3 25 | $-5.7M | $21.2M | ||
| Q2 25 | $15.0M | $-14.7M | ||
| Q1 25 | $7.0M | $16.5M | ||
| Q4 24 | $22.0M | $35.4M | ||
| Q3 24 | $8.3M | $17.8M | ||
| Q2 24 | $1.3M | $14.2M | ||
| Q1 24 | $428.0K | $23.6M |
| Q4 25 | 9.9% | 4.7% | ||
| Q3 25 | -3.6% | 8.2% | ||
| Q2 25 | 10.4% | -5.7% | ||
| Q1 25 | 4.9% | 7.4% | ||
| Q4 24 | 15.0% | 14.8% | ||
| Q3 24 | 5.5% | 7.5% | ||
| Q2 24 | 0.9% | 6.5% | ||
| Q1 24 | 0.3% | 12.2% |
| Q4 25 | 4.2% | 8.0% | ||
| Q3 25 | 4.9% | 7.2% | ||
| Q2 25 | 7.5% | 12.7% | ||
| Q1 25 | 5.2% | 13.7% | ||
| Q4 24 | 5.3% | 10.7% | ||
| Q3 24 | 6.2% | 9.9% | ||
| Q2 24 | 5.9% | 9.2% | ||
| Q1 24 | 6.1% | 5.1% |
| Q4 25 | — | 1.19× | ||
| Q3 25 | 0.04× | 0.85× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 1.30× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
TGLS
| Product Sales | $164.2M | 67% |
| Fixed Price Contracts | $81.1M | 33% |
| Related Party | $692.0K | 0% |
